Methodological approaches to evaluate teratogenic risk using birth defect registries: advantages and disadvantages.
BACKGROUND
Different approaches have been used in case-control studies to estimate maternal exposure to medications and the risk of birth defects. However, the performance of these approaches and how they affect the odds ratio (OR) estimates have not been evaluated using birth-defect surveillance programmes. The aim of this study was to evaluate the scope and limitations of three case-control approaches to assess the teratogenic risk of birth defects in mothers exposed to antiepileptic medications, insulin, or acetaminophen.


RESULTS
We studied 110,814 non-malformed newborns and 58,514 live newborns with birth defects registered by the Latin American Collaborative Study of Congenital Anomalies (ECLAMC) between 1967 and 2008. Four controls were randomly selected for each case in the same hospital and period, and three different control groups were used: non-malformed newborns (HEALTHY), malformed newborns (SICK), and a subgroup of SICK, only-exposed cases (OECA). Associations were evaluated using OR and Pearson's chi-square (P<0.01). There were no concordance correlations between the HEALTHY and OECA designs, and the average OR differences ranged from 3.0 to 11.5 for the three evaluated medicines. The overestimations observed for HEALTHY design were increased as higher OR values were given, with a high and statistically significant correlation between the difference and the mean. On the contrary, the concordance correlations obtained between the SICK and OECA designs were quite good, with no significant differences in the average risks.


CONCLUSIONS
The HEALTHY design estimates the true population OR, but shows a high rate of false-positive results presumably caused by differential misclassification bias. This bias decreases with the increase of the proportion of exposed controls. SICK and OECA odds ratios cannot be considered a direct estimate of the true population OR except under certain conditions. However, the SICK and OECA designs could provide practical information to generate hypotheses about potential teratogens.
ECLAMC (Estudio Colaborativo Latinoamericano de Malformaciones Congénitas) at Centro de Educación Médica e Investigaciones Clínicas (CEMIC) (CONICET), Buenos Aires, Argentina.
Fernando A
FA
Poletta
Jorge S
JS
López Camelo
Juan A
JA
Gili
Emmanuele
E
Leoncini
Eduardo E
EE
Castilla
Pierpaolo
P
Mastroiacovo
D000014:Abnormalities, Drug-Induced / Q000453:epidemiology*; D000082:Acetaminophen / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007328:Insulin / Q000009:adverse effects; D008297:Male; D018811:Maternal Exposure / Q000009:adverse effects*; D016017:Odds Ratio; D011247:Pregnancy; D012042:Registries; D013723:Teratogens / Q000633:toxicity*
D000927:Anticonvulsants; D007328:Insulin; D013723:Teratogens; D000082:Acetaminophen